Publications by authors named "Verschuren L"

Unexplainable gastrointestinal complaints occasionally occur after Roux-en-Y Gastric Bypass (RYGB) surgery. We therefor investigated the impact of microbiota composition and metabolites on gastrointestinal complaints after RYGB. In the BARICO study (Bariatric surgery Rijnstate and Radboudumc neuroimaging and Cognition in Obesity), microbiota and metabolites were measured before surgery, and 6, and 24 months after surgery.

View Article and Find Full Text PDF

Fibroblast growth factor 21 (FGF21) is a promising target for treatment of obesity-associated diseases including metabolic dysfunction-associated steatohepatitis (MASH) and atherosclerosis. We evaluated the effects of the bispecific anti-FGF21-β klotho (KLB) agonist antibody bFKB1 in a preclinical model of MASH and atherosclerosis. Low-density lipoprotein receptor knockout (Ldlr-/-).

View Article and Find Full Text PDF
Article Synopsis
  • A target discovery pipeline was created to identify drug targets for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis by using a combination of molecular networks, text mining, and machine learning integrated with clinical data.
  • Key genes influencing disease progression were pinpointed through knockout studies, leading to target efficacy analysis which confirmed the top-5 gene targets, including EP300, as significant contributors to liver fibrosis.
  • Gene-silencing of EP300 notably reduced collagen levels in hepatic cells, demonstrating the pipeline's effectiveness in uncovering relevant drug targets and pathways for treating liver diseases.
View Article and Find Full Text PDF

It is unclear whether early metabolic and inflammatory aberrations in the liver are associated with detrimental changes in brain structure and cognitive function. This cross-sectional study examines putative associations between metabolic dysfunction-associated steatotic liver disease (MASLD) and brain health in 36-55 year-old participants with obesity (n = 70) from the BARICO study (BAriatric surgery Rijnstate and Radboudumc neuroImaging and Cognition in Obesity). The participants underwent brain magnetic resonance imaging to study brain volumes and cortical thickness (3T MRI including T1-weighted magnetization-prepared rapid gradient-echo sequence), cerebral blood perfusion (arterial spin labeling) and white matter integrity (diffusion weighted imaging to assess mean-skeletonized mean diffusivity and fluid-attenuated inversion recovery to detect the presence of white matter hyperintensities (WMH)).

View Article and Find Full Text PDF
Article Synopsis
  • - The rise of MASLD and MASH-related fibrosis is growing globally, yet current drug therapies face challenges due to diverse patient responses and inadequate preclinical models.
  • - Researchers used a large dataset to explore the reasons behind patient differences, applying methods like weighted gene co-expression network analysis (WGCNA) to identify six distinct patient subgroups based on gene expression patterns.
  • - Their findings suggest that recognizing these subgroups could enhance patient stratification and lead to targeted treatments, highlighting the need for further research to understand these groups better and find specific protein targets for future therapies.
View Article and Find Full Text PDF

Urbanization impacts plant-herbivore interactions, which are crucial for ecosystem functions such as carbon sequestration and nutrient cycling. While some studies have reported reductions in insect herbivory in urban areas (relative to rural or natural forests), this trend is not consistent and the underlying causes for such variation remain unclear. We conducted a continental-scale study on insect herbivory along urbanization gradients for three European tree species: Quercus robur, Tilia cordata, and Fraxinus excelsior, and further investigated their biotic and abiotic correlates to get at mechanisms.

View Article and Find Full Text PDF

We previously demonstrated that diet supplementation with seaweed () prevented AD-related pathology in a mouse model of Alzheimer's Disease (AD). Here, we tested a lipid extract of seaweed () and a supercritical fluid (SCF) extract of that is free of excess inorganic arsenic. Diet supplementation with extract prevented cognitive deterioration in APPswePS1ΔE9 mice.

View Article and Find Full Text PDF
Article Synopsis
  • This study focuses on creating a blood test to identify fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) using a gene expression signature found in a mouse model.
  • Researchers developed a biomarker panel made up of three proteins: IGFBP7, SSc5D, and Sema4D, which effectively predicts different levels of liver fibrosis.
  • The new blood-based test shows better accuracy in detecting fibrosis stages compared to existing methods like Fib-4, APRI, and FibroScan, making it a promising tool for diagnosing MASLD-related liver issues.
View Article and Find Full Text PDF

With the purpose of identifying a sensitive, robust, and easy-to-measure set of biomarkers to assess stress reactivity, we here study a large set of relatively easy to obtain markers reflecting subjective, autonomic nervous system (ANS), endocrine, and inflammatory responses to acute social stress (n = 101). A subset of the participants was exposed to another social stressor the next day (n = 48) while being measured in the same way. Acute social stress was induced following standardized procedures.

View Article and Find Full Text PDF

Muscle-aging drives sarcopenia and is a major public health issue. Mice are frequently used as a model for human muscle-aging, however, research investigating their translational value is limited. In addition, mechanisms underlying muscle-aging may have sex-specific features in humans, but it is not yet assessed whether these are recapitulated in mice.

View Article and Find Full Text PDF

Common beech (Fagus sylvatica) is one of the most important deciduous tree species in European forests. However, climate-change-induced drought may threaten its dominant position. The Sonian Forest close to Brussels (Belgium) is home to some of the largest beech trees in the world.

View Article and Find Full Text PDF
Article Synopsis
  • Physical weakness, a common issue in older adults, shows significant sex differences, with women experiencing a higher prevalence and earlier onset of frailty-related weakness.
  • The study involved muscle biopsies from older adults, revealing that weak females had heightened inflammatory responses, while weak males displayed smaller muscle fiber size and unique molecular changes.
  • The findings underscore the need for sex-specific considerations in frailty research, as these differences could inform more effective interventions for combating physical weakness in older adults.
View Article and Find Full Text PDF
Article Synopsis
  • Semaglutide is an antidiabetic drug recently approved for obesity treatment and shows promise for non-alcoholic steatohepatitis (NASH) therapy.
  • In an experiment with Ldlr-/-.Leiden mice on a high-fat diet, semaglutide significantly reduced liver fat and inflammation, but did not significantly affect fibrosis.
  • The study suggests semaglutide is effective for addressing liver fat and inflammation in NASH, although additional treatments may be required for advanced fibrosis.
View Article and Find Full Text PDF
Article Synopsis
  • The prevalence of sarcopenia is on the rise, making it essential to find effective intervention tests, although existing methods can be difficult and costly.
  • Researchers evaluated three mouse models that simulate factors contributing to sarcopenia: partial immobilization (sedentary lifestyle), caloric restriction (CR), and a combination of both.
  • The findings suggested that the combined model best reflects human muscle aging by showing significant loss of muscle mass and function, highlighting the relevance of lifestyle factors like inactivity and poor nutrition in the development of sarcopenia.
View Article and Find Full Text PDF

Patients with metabolic syndrome are often prescribed statins to prevent the development of cardiovascular disease. Conversely, data on their effects on non-alcoholic steatohepatitis (NASH) are lacking. We evaluated these effects by feeding APOE*3-Leiden mice a Western-type diet (WTD) with or without atorvastatin to induce NASH and hepatic fibrosis.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) in the setting of non-alcoholic fatty liver disease (NAFLD)-related cirrhosis and even in the pre-cirrhotic state is increasing in incidence. NAFLD-related HCC has a poor clinical outcome as it is often advanced at diagnosis due to late diagnosis and systemic treatment response is poor due to reduced immune surveillance. Much of the focus of molecular research has been on the pathological changes in hepatocytes; however, immune cells, hepatic stellate cells, liver sinusoidal endothelial cells and the extracellular matrix may play important roles in the pathogenesis of NAFLD-related HCC as well.

View Article and Find Full Text PDF

Sex differences in muscle aging are poorly understood, but could be crucial for the optimization of sarcopenia-related interventions. To gain insight into potential sex differences in muscle aging, we recruited young (23 ± 2 years, 13 males and 13 females) and old (80 ± 3.5 years, 28 males and 26 females) participants.

View Article and Find Full Text PDF

Background And Objective: While underlying pathophysiology linking obesity to brain health is not completely understood, white adipose tissue (WAT) is considered a key player. In obesity, WAT becomes dysregulated, showing hyperplasia, hypertrophy, and eventually inflammation. This disbalance leads to dysregulated secretion of adipokines influencing both (cardio)vascular and brain health.

View Article and Find Full Text PDF

Background: Chronic inflammation is an important driver in the progression of non-alcoholic steatohepatitis (NASH) and atherosclerosis. The complement system, one of the first lines of defense in innate immunity, has been implicated in both diseases. However, the potential therapeutic value of complement inhibition in the ongoing disease remains unclear.

View Article and Find Full Text PDF

The prevalence of non-alcoholic steatohepatitis (NASH) is rapidly increasing and associated with cardiovascular disease (CVD), the major cause of mortality in NASH patients. Although sharing common risk factors, the mechanisms by which NASH may directly contribute to the development to CVD remain poorly understood. The aim of this study is to gain insight into key molecular processes of NASH that drive atherosclerosis development.

View Article and Find Full Text PDF

Atypical chemokine receptor 3 (ACKR3, formerly CXC chemokine receptor 7) is a G protein-coupled receptor that recruits β-arrestins, but is devoid of functional G protein signaling after receptor stimulation. In preclinical models of liver and lung fibrosis, ACKR3 was previously shown to be upregulated after acute injury in liver sinusoidal and pulmonary capillary endothelial cells, respectively. This upregulation was linked with a pro-regenerative and anti-fibrotic role for ACKR3.

View Article and Find Full Text PDF

In obesity-associated non-alcoholic steatohepatitis (NASH), persistent hepatocellular damage and inflammation are key drivers of fibrosis, which is the main determinant of NASH-associated mortality. The short-chain fatty acid butyrate can exert metabolic improvements and anti-inflammatory activities in NASH. However, its effects on NASH-associated liver fibrosis remain unclear.

View Article and Find Full Text PDF

Metabolic disorders, such as obesity and type 2 diabetes have a large impact on global health, especially in industrialized countries. Tissue-specific chronic low-grade inflammation is a key contributor to complications in metabolic disorders. To support therapeutic approaches to these complications, it is crucial to gain a deeper understanding of the inflammatory dynamics and to monitor them on the individual level.

View Article and Find Full Text PDF

Background: Non-alcoholic steatohepatitis (NASH) has become one of the most common liver diseases and is still without approved pharmacotherapy. Lifestyle interventions using exercise and diet change remain the current treatment of choice and even a small weight loss (5-7%) can already have a beneficial effect on NASH. However, the underlying molecular mechanisms of exercise and diet interventions remain largely elusive, and it is unclear whether they exert their health effects via similar or different pathways.

View Article and Find Full Text PDF